SOL Global's HeavenlyRx To Acquire Airganics

HeavenlyRx, a portfolio company of SOL Global Investments Corp SOLCF, has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million.

The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.

Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.

All brands are focused to capture the CBD wellness space and already have distribution channels.

OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles

Market News and Data brought to you by Benzinga APIs

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

The Benzinga Cannabis Capital Conference is coming to Florida